Home
Sitemap | Contact
2007
Filter     Display # 
# Article Title
1 December 18th 07 - ACE BioSciences Raises 11.9 Million Euros to Develop Diarrhoea Vaccine Portfolio
2 May 31st, 2007 - ACE BIOSCIENCES IN-LICENCES PHASE I ENTEROTOXIGENIC E COLI (ETEC) VACCINE FROM CAMBRIDGE BIOSTABILITY LTD
3 April 11th, 2007 - ACE BIOSCIENCES AND NAVAL MEDICAL RESEARCH CENTER BEGIN CAMPYLOBACTER TRIAL FOLLOWING IND APPROVAL BY US FDA
4 March 28, 2007 - ACE BIOSCIENCES' ACE393, THE WORLD'S FIRST COMMERCIAL VACCINE FOR TRAVELLERS' DIARRHOEA CAUSED BY CAMPYLOBACTER SUCCESSFULLY COMPLETES PHASE I CLINICAL TRIALS
5 March 13th, 2007 - BIOSCIENCES APPOINTS DR JUERGEN FRISCH, A SEASONED PHARMACEUTICAL EXECUTIVE WITH 20 YEARS EXPERIENCE TO THE BOARD
 
© ACE BioSciences A/S - Updated June 2009